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Abstract
Objective: To compare the clinical approach and outcomes of bron­
chopulmonary dysplasia (BPD) patients in the last two decades (1996­2005 
vs 2006­2015) in a neonatal intensive care unit. 
Methods: Out of 1,196 admissions of very low birth weight and/or less 
than 32 weeks of gestational age infants, 96 had BPD and were dichotomized 
into two groups according to the year of birth (1996­2005 and 2006­2015). 
Their clinical data were studied and conclusions were drawn about their 
morbidity and mortality. 
Results: There was a decrease in mortality (23.3% vs. 14.4%, p < 0.001) 
and in BPD prevalence (9.7% vs 6.1%, p = 0.023); in the delivery room, early 
nasal continuous positive airways pressure (nCPAP) was used in 41.2% vs 
1.6%, p < 0.001 and tracheal intubation in 70.6% vs 96.8%, p < 0.001. We 
observed an increase on the duration of non­invasive ventilation (nCPAP, 
22.5 vs 45.5 days, p < 0.001) and a decrease of invasive ventilation (39.5 vs 
20 days, p = 0.013) from the first to the second period. 
Conclusions: Improvement in perinatal and neonatal intensive care 
practices, namely the use of non­invasive methods of mechanical ventilation 
implemented in the last years, probably contributed to the better evolution of 
preterm infants with BPD. 
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Introduction
Bronchopulmonary dysplasia (BPD) is a 
frequent complication in very preterm infants 
and its multifactorial etiology has not yet been 
fully established [1, 2]. Mechanical ventilation, 
inflammation/infection and oxidative stress are 
known as important risk factors, with prematurity 
beeing the most important factor, and the incidence 
of BPD is inversely proportional to gestational age 
and birth weight [3, 4]. 
The definition of BPD has been subjected to 
changes since its first description in 1967. Initially, 
BPD was described as a consequence of positive­
pressure ventilation and oxygen therapy, which 
were responsible for severe histological lung 
lesions (inflammation, protein­rich edema, airway 
epithelial metaplasia, peribronchial fibrosis and 
hypertrophy of respiratory tract vascular smooth 
muscle): the “classic BPD” [5, 6]. 
Perinatal care has improved over the last 
decades and today very immature preterm 
infants have more chances to survive with BPD. 
These extremely low gestational age newborns 
are born in the course of the late canalicular 
or early saccular stages of lung development, 
causing disruption of the normal development 
of alveoli and vessels, despite gentle ventilation 
and less oxygen use, resulting in the “new BPD” 
[7]. Nowadays, although there is no effective 
treatment for BPD, preventive strategies are of 
great importance [8].
 The aim of this study was to compare the 
clinical approach and their effects on BPD patients 
in the last two decades (1996­2005 vs. 2006­2015) 
in very preterm infants admitted in a level III 
neonatal intensive care unit (NICU). 
Material and methods 
All preterm infants with a birth weight ≤ 1,500 
g and/or gestational age ≤ 32 weeks admitted 
between 1st January 1996 and 31st December 2015 
to the NICU of Centro Hospitalar de São João, 
a level III center in the North of Portugal, were 
considered for this retrospective study. 
We excluded all outborn neonates, children 
affected by major congenital anomalies, 
chromosomal anomalies and TORCH infections 
(Toxoplasmosis, Other [syphilis, varicella­zoster, 
parvovirus B19], Rubella, Cytomegalovirus and 
Herpes infections). The final study sample included 
1,196 infants, wherein 96 (8%) had BPD. Infants 
were dichotomized into two groups according 
to the year of NICU admission (1996­2005 and 
2006­2015).
Maternal, pregnancy and neonates clinical 
data were collected from clinical and informatics 
records, including: maternal age, infant’s gender, 
gestational age (weeks), birth weight (grams), 
antenatal steroid pulses, mode of delivery, 
respiratory support in the delivery room and in 
the NICU, Apgar score at 1 and 5 minutes (< 7 
vs. ≥ 7), exogenous surfactant therapy, oxygen 
therapy, major morbidity conditions – respiratory 
distress syndrome (RDS), BPD, pneumonia, 
pneumothorax, sepsis, meningitis, patent ductus 
arteriosus (PDA), necrotizing enterocolitis 
(NEC), severe intraventricular hemorrhage 
(IVH), retinopathy of prematurity (ROP), cystic 
periventricular leukomalacia (cPVL) –, length of 
mechanical ventilation, oxygen therapy, parenteral 
nutrition, NICU stay and survival. 
The diagnosis and classification of BPD was 
defined according to the National Institutes of 
Health [9]. 
Gestational age (completed weeks) was 
assessed by menstrual age (women with regular 
menstrual cycles), ultrasound examination (when a 
discrepancy of two or more weeks existed between 
the gestational age calculated by menstrual 
dating and the age derived sonographically or 
in the absence of a menstrual date) [10] or the 
New Ballard Score (in the absence of obstetrical 
indexes) [11]. 
Small for gestational age was defined as a birth 
weight below the 10th centile of Fenton’s fetal 
growth charts [12]. 
Early nasal continuous positive airway pressure 
(nCPAP) was considered if started in the first 15 
minutes after birth and its failure was considered 
if patients needed invasive ventilation in the first 
72 hours of life. 
RDS diagnosis was made on a combination of 
clinical and radiographic features according to the 
criteria of RDS of the Vermont Oxford Network: 
PaO
2
 < 50 mmHg in room air, a requirement for 
supplemental oxygen to maintain PaO
2
 > 50 
mmHg or to maintain a pulse oximeter saturation 
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over 85% within the first 24 hours of life, and a 
chest radiograph with reticulogranular appearance 
to lung fields with or without low lung volumes 
and air bronchograms within the first 24 hours of 
life. 
Histological chorioamnionitis was defined 
according to Blanc’s classification [13] and all the 
stages of chorioamnionitis were analyzed together. 
Proven neonatal sepsis was defined as any 
systemic bacterial or fungal infection documented 
by a positive blood culture. 
In all cases of preterm delivery whenever 
an infection cause could not be excluded, a 
combination of ampicillin and gentamicin was 
used as the first line antibiotic therapy, while 
waiting for the results of blood culture. 
For the diagnosis and staging of NEC we used 
the modified criteria of Bell [14]. 
ROP was staged according to the international 
classification [15, 16]. 
IVH was classified according to Papile et al. 
[17], and grades III and IV were considered severe. 
cPVL was classified according to de Vries and 
Rennie [18]. Hemodynamically significant PDA 
was diagnosed considering echocardiographic 
findings performed by the pediatric cardiologist 
of the hospital [19]. The first evaluation was 
usually done between 24 and 72 hours of life with 
daily evaluations until closure of the ductus. The 
standard treatment was indomethacin until 2010, 
and ibuprofen afterwards.
Until 2003, the antenatal steroid regimen 
included dexamethasone (24 mg divided into 
two intramuscular doses 12 h apart). Since then, 
treatment has consisted of betamethasone (24 mg 
divided into two intramuscular doses 24 h apart) 
in pregnancies at risk of preterm labor between 24 
and 35 weeks gestation. 
Caffeine was routinely used in all preterm 
infants since the first day of life until 34 weeks of 
corrected age [20]. 
Oxygen was used to maintain saturations 
given by pulse oximetry in the range of 88­94% 
for RDS and ≥ 95% for established BPD until 
2007. After this year, in preterm babies with RDS 
receiving oxygen, the saturation target was 90­
95% [20]. 
Spontaneous breathing infants were stabilized 
with nCPAP of at least 5­6 cmH
2
O via mask or 
nasal prongs. Intubation was used in infants who 
could not be stabilized with nCPAP [20].
Exogenous surfactant was administered for 
RDS by endotracheal tube in neonates on invasive 
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mechanical ventilation or by INSURE (intubate­
surfactant­extubate) in preterm infants on nCPAP 
requiring FiO
2
 > 0.40 and/or arterial PCO
2
 > 65 
mmHg and pH < 7.20. 
For non­invasive mechanical ventilation we 
used Infant Flow® SiPAP System (CareFusion, 
Yorba Linda, California, U.S.A.). 
In 2003 we started to use volume guarantee with 
synchronized ventilatory modes (pressure support 
ventilation, synchronized intermittent mandatory 
ventilation or synchronized intermittent positive 
pressure ventilation), using Babylog® 8000 Plus, 
(Dräger, Lübeck, Germany) and posteriorly Fabian 
HFO® (Acutronic Medical Systems, Hirzel, 
Switzerland). 
The DART protocol of dexamethasone was 
used in invasively ventilated patients that could 
not be weaned off after 10 days of life, after 2007 
[21]. Before this time, we used the Cummings 
protocol [22]. 
Parenteral nutrition was started in the first day 
of life and enteral nutrition as soon as possible, 
according to the clinical stability of the patient. 
According to our protocol, parenteral nutrition 
starts with 70­80 ml/kg/day on the first day of 
life with daily increments of 10­15 ml/kg/day to 
a maximum of 150 ml/kg/day in the first week of 
life [23]. 
The study protocol was approved by the Ethics 
Committee of Centro Hospitalar de São João. 
Statistical analysis 
Descriptive statistics were presented using 
absolute and relative frequencies for categorical 
variables, mean and standard deviations (SD), 
and median and 25­75 percentiles (P25­P75) for 
normally and non­normally distributed continuous 
variables, respectively. 
We compared two groups of infants, those 
who were admitted in 1996­2005 and those 
who were admitted in 2006­2015, using a Chi­
square test or Fisher’s exact test, as appropriate, 
when variables were categorical. For continuous 
variables Independent t­test (normally distributed 
variables) or Mann­Whitney U test (non­normally 
distributed variables) were used. A p­value below 
0.05 was considered statistically significant. 
Crude and adjusted odds ratios (OR) and their 
respective 95% confidence intervals (CI) were 
calculated using logistic regression. 
The statistical analysis was performed using 
SPSS® for Windows®, version 23. 
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Results 
Of the 1,196 infants considered for this 
analysis, 229 (19.1%) died, 149 (23.3%) in the first 
decade (1996­2005) and 80 (14.4%) in the second 
(2006­2015) (p < 0.001). The prevalence of BPD 
decreased from 9.7% in 1996­2005 to 6.1% in 
2006­2015 (p = 0.023) (Tab. 1). 
Table 1. Admissions, deceased and bronchopulmonary dysplasia (BPD) patients according to the two epochs (1996-2005 
vs. 2006-2015). 
Total 1996-2005 2006-2015 p-value
NICU admissions, n (%) 1,196 (100) 640 (53.5) 556 (46.5) 0.047 a
Deceased, n (%) 229 (19.1) 149 (23.3) 80 (14.4) < 0.001 a
Deceased and/or survivors with BPD, n (%) 325 (27.2) 211 (33.0) 114 (20.5) < 0.001 a
Survivors with BPD, n (%) 96 (8.0) 62 (9.7) 34 (6.1) 0.023 a
NICU: neonatal intensive care unit; BPD: bronchopulmonary dysplasia.
a Chi-square test.
Table 2. Maternal, prenatal, and perinatal characteristics among infants with bronchopulmonary dysplasia (BPD) by period 
of NICU admission (1996-2005 vs. 2006-2015).
 Total 
(n = 96)
1996-2005 
(n = 62) 
2006-2015 
(n = 34) p-value
Sex, n (%)     
Male 66 (68.8) 43 (69.4) 23 (67.6) 0.863 a 
Female 30 (31.3) 19 (30.6) 11 (32.4)  
Gestational age, mean (± SD) (weeks) 27.63 (0.220) 27.74 (0.250) 27.41 (0.425) 0.475 d 
Birth weight, mean (± SD) (grams) 962.53 (33.891) 995.42 (40.065) 902.56 (61.292) 0.192 d 
Small for gestational age, n (%) 22 (22.9) 10 (16.1) 12 (35.3) 0.033 a 
Less than 1,000 g, n (%) 63 (65.6) 38 (61.3) 25 (73.5) 0.227 a 
Maternal age, median (min-max) (years) 31.00 (16-42) 30.50 (16-42) 31.00 (20-39) 0.979 c 
Preeclampsia, n (%) 21 (21.9) 9 (14.5) 12 (35.3) 0.019 a 
Change in umbilical flows, n (%) 17 (17.7) 6 (9.7) 11 (32.4) 0.005 a 
Change in cerebral flows, n (%) 16 (16.7) 6 (9.7) 10 (29.4) 0.013 a 
Antenatal steroids, n (%) 87 (90.6) 55 (88.7) 32 (94.1) 0.485 b 
Full cycle 56 (65.9) 29 (54.7) 27 (84.4) 0.005 a 
Histological chorioamnionitis, n (%) 24 (25.8) 14 (23.7) 10 (29.4) 0.546 a 
Delivery mode, n (%)    
Vaginal 32 (33.3) 25 (40.3) 7 (20.6) 0.050 a 
C-section 64 (66.7) 37 (59.7) 27 (79.4)  
Apgar score, n (%)  
1st minute < 7 73 (76.0) 48 (77.4) 25 (73.5) 0.669 a 
5th minute < 7 26 (22.7) 12 (20.0) 14 (41.2) 0.027 a 
Respiratory management in the delivery room, n (%)     
Spontaneous ventilation 3 (3.1) 2 (3.2) 1 (2.9) 0.999 b 
Endotracheal intubation 84 (87.5) 60 (96.8) 24 (70.6) < 0.001 b 
Early nCPAP 15 (15.6) 1 (1.6) 14 (41.2) < 0.001 b 
nCPAP: nasal continuous positive airway pressure.
a Chi-square test; b Fisher’s exact test; c Mann-Whitney U test, d Independent t test.
Tab. 2 summarizes the maternal, pregnancy and 
BPD infants characteristics in both epochs. Overall, 
68.8% of infants were male with a mean (SD) GA 
of 27.6 (0.22) weeks and a mean birth weight of 
962.5 (33.89) grams. As reported in Tab. 3, there 
was a significant decrease in invasive mechanical 
ventilation median duration (39.50 days in 1996­
2005 and 20.00 in 2006­2015, p = 0.013) and a 
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significant increase in nCPAP duration (22.50 
days in 1996­2005 and 45.50 days in 2006­2015, 
p < 0.001). ROP grade ≥ 2 and severe IVH had a 
significant increase in the second decade (22.6% 
vs. 44.1% [p = 0.028] and 12.9% vs. 38.2% [p = 
0.004], respectively). There was a significant lower 
prevalence of nosocomial sepsis in the second 
decade (83.9% vs. 64.7%, p = 0.033). 
Infants admitted during the second epoch were 
more likely to have ROP grade ≥ 2 (OR = 8.112, 
95%CI: 1.396­47.134; p = 0.020) and severe IVH 
(OR = 12.313, 95%CI: 1.921­78.920; p = 0.008). 
Discussion 
In the last decades there have been several 
changes in perinatal care around the world 
with a consequent implementation of better 
clinical practices during pregnancy as well 
as in management of the preterm infants. Our 
center accompanied these changes showing an 
improvement in morbimortality of these very 
preterm infants. 
There has been a statistically significant 
increase in pregnancy­associated pathologies as 
Table 3. Morbimortality and management of infants with bronchopulmonary dysplasia (BPD), by period of NICU admission 
(1996-2005 vs. 2006-2015).
 Total (n = 96) 
1996-2005 
(n = 62) 
2006-2015 
(n = 34) p-value
RDS, n (%) 88 (91.7) 55 (88.7) 33 (97.1) 0.253 b 
Surfactant administration, n (%) 81 (84.4) 51 (82.3) 30 (88.2) 0.563 b 
Surfactant doses, median (min-max) 2.00 (1-5) 2.00 (1-3) 2.00 (1-5) 0.361 c
Invasive mechanical ventilation, n (%) 90 (93.8) 60 (96.8) 30 (88.2) 0.181 b 
Invasive mechanical ventilation, median (min-max) (days)  30.50 (1-211) 39.50 (1-211) 20.00 (2-138) 0.013 c 
nCPAP, n (%) 82 (85.4) 50 (80.6) 32 (94.1) 0.128 b 
nCPAP, median (min-max) (days) 32.00 (1-161) 22.50 (1-161) 45.50 (7-76) < 0.001 c 
Oxygen, n (%) 96 (100) 62 (100) 34 (100) - 
Oxygen, median (min-max) (days) 70.00 (22-260) 69.00 (28-260) 71.50 (22-191) 0.412 c 
BPD, n (%)     
Mild/Moderate 70 (72.9) 43 (69.4) 27 (79.4) 0.458 a 
Severe 26 (27.1) 19 (30.6) 7 (20.6)  
PDA, n (%) 65 (67.7) 43 (69.4) 22 (64.7) 0.641 a 
With medical treatment 59 (95.2) 37 (94.9) 22 (95.7) 0.999 b 
With surgical treatment 10 (16.1) 4 (10.3) 6 (26.1) 0.153 b 
Nosocomial sepsis, n (%) 74 (77.1) 52 (83.9) 22 (64.7) 0.033 a 
NEC ≥ 2a, n (%) 3 (3.1) 3 (4.8) 0 (0) 0.550 b 
ROP ≥ 2, n (%) 29 (30.2) 14 (22.6) 15 (44.1) 0.028 a 
IVH ≥ III, n (%) 21 (21.9) 8 (12.9) 13 (38.2) 0.004 a 
cPVL, n (%) 7 (7.3) 4 (6.5) 3 (8.8) 0.695 b 
Parenteral nutrition, n (%) 95 (99.0) 61 (98.4) 34 (100) 0.999 b 
Parenteral nutrition, median (min-max) (days) 36.00 (8-145) 40.00 (8-145) 33.0 (12-101) 0.070 c 
NICU stay, median (min-max) (days) 78.50 (21-259) 74.00 (29-259) 86.00 (21-191) 0.191 c 
Sequels, n (%)     
O2 requirement 25 (30.1) 14 (26.4) 11 (36.7) 0.328 a 
Tracheostomy 2 (2.4) 1 (1.9) 1 (3.3) 0.999 b 
No feeding autonomy 1 (1.2) 1 (1.9) 0 (0) 0.999 b 
Jejune/ileostomy 1 (1.2) 1 (1.9) 0 (0) 0.999 b 
Ventriculoperitoneal shunt 2 (2.4) 0 (0) 2 (6.7) 0.128 b 
Deceased, n (%) 13 (13.5) 9 (14.5) 4 (11.8) 0.999 b 
a Chi-square test; b Fisher’s exact test; c Mann-Whitney U test.
RDS: respiratory distress syndrome; nCPAP: nasal continuous positive airway pressure; BPD: bronchopulmonary dysplasia; PDA: 
patent ductus arteriosus; NEC: necrotizing enterocolitis; ROP: retinopathy of prematurity; IVH: intraventricular hemorrhage; cPVL: cystic 
periventricular leukomalacia; NICU: neonatal intensive care unit.
Impact of changes in perinatal care on BPD
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preeclampsia and cerebral and umbilical flows 
changes, which may be related to the birth of more 
small for gestational age infants and consequently 
with more severe neonatal outcome. However, 
part of this increase may be due to a better prenatal 
screening over the last years. 
Although some studies showed that 
hypertensive diseases during pregnancy are a 
protective factor for major IVH [24, 25], our 
results did not show a decrease in IVH despite 
the observed increase of hypertensive diseases on 
pregnancy. 
At the end of the twentieth century, the National 
Institutes of Health and the American College of 
Obstetricians and Gynecologists published a con­
sensus statement defending the use of antenatal 
steroids in preterm deliveries of 24 to 34 weeks of 
gestational age in order to induce fetal maturation 
and reduce the risks for RDS, IVH and neonatal 
death [26]. According to our results the number of 
completed antenatal steroids cycles increased since 
2006, showing improvement on obstetrical practices. 
The admission of more small for gestational 
age infants and preterm newborns with lower 
Apgar scores at 5 minutes in the second decade 
among the BPD patients can explain the increase 
in prevalence of ROP and IVH. 
Despite the clear admission of more severe 
patients in the second decade, we found a 
statistically significant decrease in invasive 
mechanical ventilation use (and in its duration) 
and an increase in the use and duration of non­
invasive mechanical ventilation (nCPAP). 
Also, at the delivery room, there was a higher 
prevalence of use of early nCPAP, and this fact 
highlights better neonatal practices [27]. Invasive 
mechanical ventilation is a well­known risk factor 
for the development of BPD and all efforts must 
be done to implement non­invasive mechanical 
ventilation in this high­risk group of preterm 
infants [3, 28]. 
Another fact that reinforces the improvement 
in practices in perinatal and neonatal care at our 
center is the statistically significant decrease 
of nosocomial sepsis prevalence, a fact already 
reported in another study [29]. The importance of 
this data was highlighted in a recent multicenter 
study showing that sepsis is one of the most 
common causes of deaths in NICUs [30] and BPD 
development [3, 28]. 
With regard to BPD severity, our data show 
that there was a lower proportion of severe BPD 
diagnosed in the second decade of the study. 
Probably, in the first ten years of the study, severe 
BPD was related to the greater use of invasive 
mechanical ventilation.
Although there were no significant differences 
in gestational age and birth weight between the 
two periods of our study, in the second one more 
severe patients were admitted, proven by worse 
Apgar scores as mentioned previously. As we 
have shown before, clinical practices in neonatal 
intensive care units differ one from the other and 
benchmarking among them it’s crucial to improve 
outcomes [31]. 
With respect to clinical status, at discharge 
there were no significant differences between the 
two epochs. Taking into account that in the second 
decade more severe infants were admitted, this 
seems to be encouraging information. 
There are some major limitations of this study. 
It is a single center study and so the results cannot 
be generalized. Its retrospective nature makes it 
difficult to obtain data, especially those from the 
first period. We included preterm neonates with 
less than 32 weeks of gestational age. Recently, 
most of the studies have focused on newborns 
with gestational age less than 29 weeks, because 
the 29­32 weeks neonates are at a lower risk of 
morbidity and mortality. This aspect should be 
taken into account when comparing the results. 
 Anyway, the strength of our study is that 
it shows a decrease in BPD prevalence and 
mortality associated to an increase in the use 
of early nCPAP and non­invasive ventilation 
practices, along with a decrease of nosocomial 
sepsis prevalence.
In conclusion, the improvement in perinatal 
and neonatal intensive care practices implemented 
over the last years, contributed to the better 
evolution of our preterm infants. Moreover, 
even in the absence of an effective therapy for 
BPD, professionals should be sensitized to the 
preventive management of these preterm infants. 
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